Health Tech Co. Overstated AI Capabilities, Investor Suit Says
By Katryna Perera · June 13, 2025, 8:00 PM EDT
Health technology company Tempus AI Inc. and two of its executives face a shareholder class action over claims the company misrepresented its artificial intelligence capabilities, the value of its contracts and...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login